Bill Ackman Reduces Valeant Stake To Benefit Clients |
| December 15, 2016 | December 2016 Bond Updates |
|
As another tumultuous year has wiped out nearly 85% of Valeant Pharmaceuticals’ market value, Bill Ackman (Trades, Portfolio), one of its biggest investors, sold some shares to give his clients a year-end tax break. Ackman’s Pershing Square hedge fund initiated its Valeant (NYSE:VRX) position in early 2015 during the drugmaker’s heyday [...] |
| View more at: http://www.forbes.com/sites/gurufocus/2016/12/14/bill-ackman-reduces-valeant-stake-to-benefit-clients/ |
| Related News |